Low estrogen receptor (ER) positive breast cancer and neoadjuvant systemic therapy (NAT): Is response similar to ER plus or to ER- disease?

被引：1
|
作者：
Landmann, Alessandra
Farrugia, Daniel J.
Diego, Emilia
Soran, Atilla
Johnson, Ronald
Bonaventura, Marguerite
Dabbs, David J.
Clark, Beth
Brufsky, Adam
Davidson, Nancy E.
Lembersky, Barry C.
Jankowitz, Rachel Catherine
Puhalla, Shannon
Ahrendt, Gretchen M.
McAuliffe, Priscilla F.
Bhargava, Rohit
机构：
[1] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA
[2] Univ Pittsburgh, Pittsburgh, PA USA
[3] UPMC, Magee Womens Hosp, Pittsburgh, PA USA
[4] Magee Womens Hosp, Pittsburgh, PA USA
[5] Magee Womens Hosp, Dept Path, Pittsburgh, PA USA
[6] NRG Oncol NSABP, Pittsburgh, PA USA
[7] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.580
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
580
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Low Estrogen Receptor ( ER)-Positive Breast Cancer and Neoadjuvant Systemic Chemotherapy Is Response Similar to Typical ER-Positive or ER-Negative Disease?
    Landmann, Alessandra
    Farrugia, Daniel J.
    Zhu, Li
    Diego, Emilia J.
    Johnson, Ronald R.
    Soran, Atilla
    Dabbs, David J.
    Clark, Beth Z.
    Puhalla, Shannon L.
    Jankowitz, Rachel C.
    Brufsky, Adam M.
    Ahrendt, Gretchen M.
    McAuliffe, Priscilla F.
    Bhargava, Rohit
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2018, 150 (01) : 34 - 42
  • [2] Tamoxifen Resistance in Estrogen Receptor Positive (ER plus ) Breast Cancer Is Driven by Estrogen Receptor Negative (ER-) Cancer Stem-Like Cells.
    O'Brien, C. S.
    Howell, S. J.
    Gee, J.
    Lykkesfeldt, A. E.
    Nicholson, R., I
    Clarke, R. B.
    CANCER RESEARCH, 2009, 69 (24) : 807S - 807S
  • [3] ER-α36, a variant of ER-α, is the estrogen receptor that mediates mitogenic estrogen signaling in breast cancer cells
    Ding, L.
    Zhang, X. T.
    Wang, Z. Y.
    CANCER RESEARCH, 2009, 69 (02) : 68S - 68S
  • [4] Characterization of Estrogen Receptor Negative/Progesterone Receptor Positive/(ER-/PR plus ) Breast Cancer (BC)
    Shen, Tiansheng
    Brandwein-Gensler, Margaret
    Hameed, Omar
    Siegal, Gene
    Wei, Shi
    MODERN PATHOLOGY, 2015, 28 : 65A - 65A
  • [5] Characterization of Estrogen Receptor Negative/Progesterone Receptor Positive/(ER-/PR plus ) Breast Cancer (BC)
    Shen, Tiansheng
    Brandwein-Gensler, Margaret
    Hameed, Omar
    Siegal, Gene
    Wei, Shi
    LABORATORY INVESTIGATION, 2015, 95 : 65A - 65A
  • [6] Expression of estrogen receptor (ER-α and ER-β) mRNA in human prostate cancer
    Ito, T
    Tachibana, M
    Yamamoto, S
    Nakashima, J
    Murai, M
    EUROPEAN UROLOGY, 2001, 40 (05) : 557 - 563
  • [7] Estrogen Receptor Alpha Negative (ER-) Breast Cancer Stem Cells in ER plus Cell Lines and Primary Cancers Are Enriched by Tamoxifen Therapy
    O'Brien, C. S.
    Howell, S. J.
    Gandhi, A.
    Gee, J.
    Lykkesfeldt, A.
    Nicholson, R. I.
    Clarke, R. B.
    CANCER RESEARCH, 2010, 70
  • [8] Combination of bazedoxifene and lapatinib profoundly inhibits estrogen receptor positive (ER plus ) and Negative (ER-) mammary tumorigenesis
    Mohammed, Altaf
    Sei, Shizuko
    Shoemakers, Robert
    Grubbs, Clinton J.
    CANCER RESEARCH, 2020, 80 (16)
  • [9] Endocrine therapy resistance in estrogen receptor (ER)-positive breast cancer
    De Marchi, Tommaso
    Foekens, John A.
    Umar, Arzu
    Martens, John W. M.
    DRUG DISCOVERY TODAY, 2016, 21 (07) : 1181 - 1188
  • [10] Late disease recurrence in estrogen receptor positive (ER plus ) premenopausal breast cancer (BC)
    Recchia, Francesco
    Candeloro, Giampiero
    Necozione, Stefano
    Rea, Silvio
    Hoo, William Soo
    Cantor, Tom
    CANCER RESEARCH, 2014, 74 (19)
12345